NOX4 and pulmonary fibrosis: Experimentally, mice with deficient NOX4 exhibited a significantly less severe fibrotic phenotype in the lungs of a bleomycin-induced pulmonary fibrosis mouse model [25], suggesting that NOX4 was a potential target for treatment of pulmonary fibrosis including silicosis.